Dimed Distribuidora de Medicamentos (BSP:PNVL3) Total Stockholders Equity: R$1,317 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSP:PNVL3 Dimed SA Distribuidora de Medicamentos BSP:PNVL3
87 GF Score
Price R$13.16
GF Value R$13.14
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Dimed Distribuidora de Medicamentos Total Stockholders Equity?

Dimed Distribuidora de Medicamentos BSP:PNVL3 +2.33% 87 Total Stockholders Equity is R$1,317 Mil as of Jun. 2026. GuruFocus rates BSP:PNVL3 with a GF Score™ of 87/100 and a GF Value™ of R$13.14 (Fairly Valued). The stock has 4 warning signs investors should review.

Dimed Distribuidora de Medicamentos's Total Stockholders Equity for the quarter that ended in Jun. 2026 was R$1,317 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Dimed Distribuidora de Medicamentos's Book Value per Share for the quarter that ended in Jun. 2026 was R$8.82. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Dimed Distribuidora de Medicamentos's Debt-to-Equity for the quarter that ended in Jun. 2026 was 1.07.

Dimed Distribuidora de Medicamentos  (BSP:PNVL3) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Dimed Distribuidora de Medicamentos's Book Value per Share for the quarter that ended in Jun. 2026 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(1317.019-0)/149.376
=8.82

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Dimed Distribuidora de Medicamentos's Debt-to-Equity for the quarter that ended in Jun. 2026 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(286.187 + 1117.563) / 1317.019
=1.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dimed Distribuidora de Medicamentos Total Stockholders Equity Related Terms

Dimed Distribuidora de Medicamentos Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Dimed Distribuidora de Medicamentos's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dimed Distribuidora de Medicamentos Total Stockholders Equity Chart

Dimed Distribuidora de Medicamentos Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,046.20 1,108.16 1,173.42 1,234.71 1,281.85

Dimed Distribuidora de Medicamentos Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,234.10 1,264.17 1,281.85 1,300.27 1,317.02
BSP:PNVL3
87GF Score
Dimed SA Distribuidora de Medicamentos BSP:PNVL3
Total Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Total Stockholders Equity of R$1,317 Mil mean?
Dimed Distribuidora de Medicamentos (BSP:PNVL3) has a Total Stockholders Equity of R$1,317 Mil as of Jun. 2026. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Dimed Distribuidora de Medicamentos and its competitors.
Is Dimed Distribuidora de Medicamentos' Total Stockholders Equity too high?
Dimed Distribuidora de Medicamentos' current Total Stockholders Equity is R$1,317 Mil. Overall, Dimed Distribuidora de Medicamentos has a GF Score™ of 87/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Dimed Distribuidora de Medicamentos' Total Stockholders Equity compare to LLY and JNJ?
Dimed Distribuidora de Medicamentos' Total Stockholders Equity of R$1,317 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Drug Manufacturers company?
A good Total Stockholders Equity depends on the Drug Manufacturers industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Dimed Distribuidora de Medicamentos and its competitors. Dimed Distribuidora de Medicamentos's current Total Stockholders Equity is R$1,317 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dimed Distribuidora de Medicamentos stock overvalued right now?
Based on GuruFocus' analysis, Dimed Distribuidora de Medicamentos (BSP:PNVL3) is currently considered Fairly Valued. The stock's GF Value™ is R$13.14, compared to a current price of R$13.16 — trading 0.2% above its estimated fair value. The current Total Stockholders Equity is R$1,317 Mil. Dimed Distribuidora de Medicamentos' overall GF Score™ is 87/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For Dimed Distribuidora de Medicamentos (BSP:PNVL3), the current Total Stockholders Equity is R$1,317 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dimed Distribuidora de Medicamentos (BSP:PNVL3) Overvalued in 2026?

Based on GuruFocus' analysis, Dimed Distribuidora de Medicamentos stock appears to be overvalued. The current stock price of R$13.16 is trading 0.2% above its estimated GF Value™ of R$13.14. GuruFocus considers Dimed Distribuidora de Medicamentos to be Fairly Valued.

Key valuation signals for BSP:PNVL3:

  • Total Stockholders Equity: R$1,317 Mil
  • GF Value™: R$13.14 vs. price of R$13.16 (0.2% above fair value)
  • GF Score™: 87/100 with 4 warning signs

No single metric tells the full story. See the BSP:PNVL3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Dimed Distribuidora de Medicamentos Business Description

Address Avenida Industrial Belgraf, 865, Eldorado do Sul, RS, BRA, 92990-000
Dimed SA Distribuidora de Medicamentos is engaged in the sale of medicines, perfumery, personal care and beauty products, cosmetics and dermocosmetics. It has single reportable segment that is, The Retail segment. The Retail segment has 556 stores that sell more than 15,000 items among drugs and personal care and beauty products. In addition to adding divisions of cosmetics, drugs and food, Lifar is responsible for the production of brands in Brazil, as well as products of its own brand Panvel.
87GF Score

Get the complete analysis for BSP:PNVL3

Total Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$13.16
Price
R$13.14
GF Value